BRCA1-IN-2 is a cell-permeable protein-protein interaction (PPI) inhibitor for BRCA1 (IC50: 0.31 μM; Kd: 0.3 μM). It has antitumor activities via the disruption of BRCA1 (BRCT)2/protein interactions.

1622262-55-8

C26H33N4O7P

544.54

BRCA1-IN-2

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years